Clinical Trial Update: Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial of Clofarabine, Cytarabine, and Thymoglobulin as part of allogeneic transplantation in myelodysplastic syndromes and acute myeloid leukemia was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Clolar (Clofarabine)
• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Myelodysplastic Syndromes, Acute Myeloid Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2014-09-12